Market

Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront…

The awards were divided in three categories

Industry hails news, awaits further details

Merck Serono and Sutro Biopharma, San Francisco, a bio-pharmaceutical company developing antibody drug conjugates and bispecific…

The stake will be acquired from BRL at a valuation of Rs 3800 crores

Announces alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer’s disease

MoUs aimed at facilitating market access, cooperation on drug regulations could increase inroads into China pharma market

Cipla has signed an agreement with Salix Pharmaceuticals, a US-based speciality pharmaceutical company. Under the agreement, Cipla…

10 therapies have outgrown the IPM growth and six therapies have double digit growths

The event in Bangalore will discuss about the importance of investing in biotechnology in India

Leaders discuss legal issues and challenges related to the pharma industry at the event

Union Health Minister shares plans for launch of national health insurance cover in the country

Commit to control and eliminate vector-borne diseases

To enter Czech Republic and Slovakia with affordable high quality alternatives

To market meropenem in three European countries

Roche to fully acquire InterMune at a price of $74.00 per share

WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tablet

IPEC India is the fifth member of the IPEC Federation

As per agreement, NITD will fully transfer its TB R&D programme to TB Alliance